Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy - Evaluation by15O-water PET

Circulation Journal

Volumn 71, Issue 6, 2007, Pages 884-890

  Ohba, Muneo ^a   Hosokawa, Ryohei ^b   Kambara, Naoshige ^a   Tadamura, Eiji ^a   Mamede, Marcelo ^a   Kubo, Shigeto ^a   Yamamuro, Masaki ^a   Fujita, Masatoshi ^c   Kimura, Takeshi ^a   Nohara, Ryuji ^b   Kita, Toru ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kitano Hospital   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Myocardial flow reserve; Positron emission tomography (PET)

Indexed keywords

OXYGEN 15;

ADULT; ARTICLE; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; FEMALE; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MALE; POSITRON EMISSION TOMOGRAPHY;

BLOOD FLOW VELOCITY; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; DILATATION, PATHOLOGIC; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MICROCIRCULATION; MIDDLE AGED; MYOCARDIUM; SYSTOLE; VASODILATION;

EID: 34249733742     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.71.884     Document Type: Article

References (47)

1. Gould KL, Lipscomb K, Hamilton GW. Physiologic basis for assessing critical coronary stenosis: Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol 1974; 33: 87-94.
2. Gould KL, Lipscomb K. Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 1974; 34: 48-55.
3. Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, et al. Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 1992; 85: 1899-1911.
4. Redberg RF, Sobol Y, Chou TM, Malloy M, Kumar S, Botvinick E, et al. Adenosine-induced coronary vasodilatation during transesophageal doppler echocardiography: Rapid and safe measurement of coronary flow reserve ratio can predict significant left anterior descending coronary stenosis. Circulation 1995; 92: 190-196.
5. Hozumi T, Yoshida K, Ogata Y, Akasaka T, Asami Y, Takagi T, et al. Noninvasive assessment of significant left anterior descending coronary artery stenosis by coronary flow velocity reserve with transthoracic color doppler echocardiography. Circulation 1998; 97: 1557-1562.
6. Shibata M, Sakuma H, Isaka N, Takeda K, Higgins CB, Nakano T. Assessment of coronary flow reserve with fast cine phase contrast magnetic resonance imaging: Comparison with measurement by Doppler guide wire. J Magn Reson Imaging 1999; 10: 563-568.
7. Sugihara H, Yonekura Y, Kataoka K, Fukai D, Kitamura N, Taniguchi Y. Estimation of coronary flow reserve with the use of dynamic planar and SPECT images of Tc-99m tetrofosmin. J Nucl Cardiol 2001; 8: 575-579.
8. Uren NG, Melin JA, Bruyne BD, Wijns W, Baudhuin T, Camici PG. Relation between myocardial blood flow and the severity of coronary-artery stenosis. N Engl J Med 1994; 330: 1782-1788.
9. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, et al. Coronary and peripheral blood flow: Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88: 62-69.
10. Czernin J, Sun K, Brunken RC, Bottcher M, Phelps M, Schelbert H. Effect of acute and long-term smoking on myocardial blood flow and flow reserve. Circulation 1995; 91: 2891-2897.
11. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M. Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 1996; 94: 3232-3238.
12. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Aoyagi T, et al. Altered myocardial vasodilatation in patients with hypertriglyceridemia in anatomically normal coronary arteries. Arterioscler Thromb Vasc Biol 1998; 18: 294-299.
13. Yokoyama I, Momomura S, Ohtake T, Yonekura K, Nishikawa J, Sasaki Y, et al. Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. J Am Coll Cardiol 1997; 30: 1472-1477.
14. Motz W, Strauer BE. Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 1996; 27: 1031-1038.
15. Nagamichi S, Czernin J, Kim AS, Sun KT, Bottcher M, Phelps ME, et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 1996; 37: 1626-1631.
16. Kaufmann PA, Gnecchi-Ruscone T, Yap JT, Rimoldi OE, Camici PG. Assessment of the reproducibility of baseline and hyperemic myocardial blood flow measurements with 15O-labeled water and PET. J Nucl Med 1999; 40: 1848-1856.
17. Jagathesan R, Kaufmann PA, Rosen SD, Rimoldi OE, Turkeimer F, Foale R, et al. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease. J Nucl Med 2005; 46: 212-219.
18. Teragaki M, Yanagi S, Toda I, Sakamoto K, Hirata K, Takeuchi K, et al. Coronary flow reserve correlates left ventricular diastolic dysfunction in patients with dilated cardiomyopathy. Cathet Cardiovasc Intervent 2003; 58: 43-50.
19. Neglia D, Parodi O, Gallopin M, Sambuceti G, Giorgetti A, Pratali L, et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure: A quantitative assessment by positron emission tomography. Circulation 1995; 92: 796-804.
20. Neglia D, Michelassi C, Trivieri MG, Sambuceti G, Giorgetti A, Pratali L, et al. Prognostic role of myocardial blood flow impairment in idiopathic left ventricular dysfunction. Circulation 2002; 105: 186-193.
21. Treasure CB, Vita JA, Cox DA, Fish RD, Gordon JB, Mudge GH, et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation 1990; 81: 772-779.
22. Opherk D, Schwarz F, Mall G, Manthey J, Baller D, Kubler W. Coronary dilatory capacity in idiopathic dilated cardiomyopathy: Analysis of 16 patients. Am J Cardiol 1983; 51: 1657-1662.
23. Inoue T, Sakai Y, Morooka S, Hayashi T, Takayanagi K, Yamaguchi H, et al. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J 1994; 127: 376-381.
24. Nitenberg A, Foult JM, Blanchet F, Zouioueche S. Multifactorial determinants of reduced coronary flow reserve after dipyridamole in dilated cardiomyopathy. Am J Cardiol 1985; 55: 748-754.
25. Cannon RO, Rosing DR, Maron BJ, Leon MB, Bonow RO, Watson RM, et al. Myocardial ischemia in patients with hypertrophic cardiomyopathy: Contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures. Circulation 1985; 71: 234-243.
26. Lorenzoni R, Gistri R, Cecchi F, Olivotto I, Chiriatti G, Elliott P, et al. Coronary vasodilator reserve is impaired in patients with hypertrophic cardiomyopathy and left ventricular dysfunction. Am Heart J 1998; 136: 972-981.
27. Krams R, Kofflard MJ, Duncker DJ, Von Birqelen C, Carlier S, Kliffen M, et al. Decreased coronary flow reserve in hypertrophic cardiomyopathy is related to remodeling of the coronary microcirculation. Circulation 1998; 97: 230-233.
28. Schwartzkopff B, Mundhenke M, Strauer BE. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: A possible cause for myocardial ischemia. J Am Coll Cardiol 1998; 31: 1089-1096.
29. Cecchi F, Olivotto L, Gistri R, Lorenzoni R, Chiriatti G, Camici PG. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. N Engl J Med 2003; 349: 1027-1035.
30. Camici PG, Chiriatti G, Lorenzoni R, Bellina RC, Gistri R, Italiani G, et al. Coronary vasodilation is impaired in both hypertrophied and nonhypertrophied myocardium of patients with hypertrophic cardiomyopathy: A study with nitrogen-13 ammonia and positron emission tomography. J Am Coll Cardiol 1991; 17: 879-886.
31. Watanabe K, Sekiya M, Ikeda S, Miyagawa M, Kinoshita M, Kumano S. Comparison of adenosine triphosphate and dipyridamole in diagnosis by thallium-201 myocardial scintigraphy. J Nucl Med 1997; 38: 577-581.
32. Iida H, Takahashi A, Tamura Y, Ono Y, Lammertsma AA. Myocardial blood flow: Comparison of oxygen-15-water bolus injection, slow infusion and oxygen-15-carbon dioxide slow inhalation. J Nucl Med 1995; 36: 78-85.
33. Iida H, Rhodes CG, de Silva R, Araujo LI, Bloomfield PM, Lammertsma AA, et al. Use of the left ventricular time-activity curve as a noninvasive input function in dynamic oxygen-15-water positron emission tomography. J Nucl Med 1992; 33: 1669-1677.
34. Kanayama S, Matsunari I, Hirayama A, Kitayama M, Matsudaira M, Yoneyama T, et al. Assessment of global and regional left ventricular function by electrocardiographic gated N-13 ammonia positron emission tomography in patients with coronary artery disease. Circ J 2005; 69: 177-182.
35. Kubo S, Tadamura E, Toyoda H, Mamede M, Yamamuro M, Magata Y, et al. Effect of caffeine intake on myocardial hyperemic flow induced by adenosine triphosphate and dipyridamole. J Nucl Med 2004; 45: 730-738.
36. Tadamura E, Iida H, Matsumoto K, Mamede M, Kubo S, Toyoda H, et al. Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in the normal men. J Am Coll Cardiol 2001; 37: 130-136.
37. Miyagawa M, Kumano S, Sekiya M, Watanabe K, Akutsu H, Imachi T, et al. Thallium-201 myocardial tomography with intravenous infusion of adenosine triphosphate in diagnosis of coronary artery disease. J Am Coll Cardiol 1995; 26: 1196-1201.
38. 15O and dynamic positron-emission tomography: Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78: 104-115.
39. Kawai C, Fujiwara H. Intramyocardial small arteries. Prog Cardiol 1989; 2: 33-43.
40. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy. Am J Cardiol 1987; 60: 123-129.
41. Seiler C, Jenni R, Vassalli G, Turina M, Hess OM. Left ventricular chamber dilatation in hypertrophic cardiomyopathy: Related variables and prognosis in patients with medical and surgical therapy. Br Heart J 1995; 74: 508-516.
42. Ten Cate FJ, Roelandt J. Progression to left ventricular dilation in patients with hypertrophic obstructive cardiomyopathy. Am Heart J 1979; 97: 762-765.
43. Ishikawa S, Nishiyama S, Nakanishi S, Nishimura S, Yanagishita Y, Kato K, et al. Natural history of 82 patients with hypertrophic cardiomyopathy: Follow-up for over ten years. J Cardiol 1991; 21: 61-73.
44. Maron BJ, Mckenna WJ. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 42: 1687-1713.
45. Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol 1998; 81: 1339-1344.
46. Moon JC, Reed E, Sheppard MN, Elkington AG, Ho SY, Burke M, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004; 43: 2260-2264.
47. Ohtani K, Yutani C, Nagata S, Koretsune Y, Hori M, Kamada T. High prevalence of atrial fibrosis in patients with dilated cardiomyopathy. J Am Coll Cardiol 1995; 25: 1162-1169.